Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey. more
Time Frame | BMY | Sector | S&P500 |
---|---|---|---|
1-Week Return | 0.04% | -3.35% | -2.97% |
1-Month Return | -3.31% | -3.49% | -0.66% |
3-Month Return | 14.85% | -12.6% | 2.71% |
6-Month Return | 37.18% | -6.91% | 7.21% |
1-Year Return | 8.04% | 1.19% | 23.04% |
3-Year Return | -8.78% | -0.21% | 28.43% |
5-Year Return | -10.42% | 33.09% | 82.88% |
10-Year Return | -8.16% | 93.55% | 184.63% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 26.14B | 42.52B | 46.38B | 46.16B | 45.01B | [{"date":"2019-12-31","value":56.37,"profit":true},{"date":"2020-12-31","value":91.66,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":99.51,"profit":true},{"date":"2023-12-31","value":97.03,"profit":true}] |
Cost of Revenue | 8.08B | 11.77B | 9.94B | 10.14B | 10.69B | [{"date":"2019-12-31","value":68.61,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":84.43,"profit":true},{"date":"2022-12-31","value":86.1,"profit":true},{"date":"2023-12-31","value":90.83,"profit":true}] |
Gross Profit | 18.07B | 30.75B | 36.45B | 36.02B | 34.31B | [{"date":"2019-12-31","value":49.57,"profit":true},{"date":"2020-12-31","value":84.36,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":98.84,"profit":true},{"date":"2023-12-31","value":94.15,"profit":true}] |
Gross Margin | 69.10% | 72.31% | 78.57% | 78.04% | 76.24% | [{"date":"2019-12-31","value":87.95,"profit":true},{"date":"2020-12-31","value":92.03,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":99.32,"profit":true},{"date":"2023-12-31","value":97.03,"profit":true}] |
Operating Expenses | 12.15B | 28.57B | 27.91B | 26.92B | 34.31B | [{"date":"2019-12-31","value":35.42,"profit":true},{"date":"2020-12-31","value":83.26,"profit":true},{"date":"2021-12-31","value":81.33,"profit":true},{"date":"2022-12-31","value":78.45,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | 5.46B | 5.13B | 10.16B | 10.33B | 17.24B | [{"date":"2019-12-31","value":31.69,"profit":true},{"date":"2020-12-31","value":29.74,"profit":true},{"date":"2021-12-31","value":58.92,"profit":true},{"date":"2022-12-31","value":59.9,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Total Non-Operating Income/Expense | (1.15B) | (8.84B) | (10.64B) | (11.87B) | (9.95B) | [{"date":"2019-12-31","value":-114500000000,"profit":false},{"date":"2020-12-31","value":-883700000000,"profit":false},{"date":"2021-12-31","value":-1063700000000,"profit":false},{"date":"2022-12-31","value":-1187000000000,"profit":false},{"date":"2023-12-31","value":-994600000000,"profit":false}] |
Pre-Tax Income | 4.97B | (6.87B) | 8.10B | 7.71B | 8.44B | [{"date":"2019-12-31","value":58.95,"profit":true},{"date":"2020-12-31","value":-81.41,"profit":false},{"date":"2021-12-31","value":95.95,"profit":true},{"date":"2022-12-31","value":91.39,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income Taxes | 1.51B | 2.12B | 1.08B | 1.37B | 400.00M | [{"date":"2019-12-31","value":71.33,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":51.04,"profit":true},{"date":"2022-12-31","value":64.41,"profit":true},{"date":"2023-12-31","value":18.83,"profit":true}] |
Income After Taxes | 3.46B | (8.99B) | 7.01B | 6.34B | 8.04B | [{"date":"2019-12-31","value":43.03,"profit":true},{"date":"2020-12-31","value":-111.88,"profit":false},{"date":"2021-12-31","value":87.24,"profit":true},{"date":"2022-12-31","value":78.92,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income From Continuous Operations | 6.49B | (8.99B) | 7.01B | 6.34B | 8.30B | [{"date":"2019-12-31","value":78.16,"profit":true},{"date":"2020-12-31","value":-108.33,"profit":false},{"date":"2021-12-31","value":84.48,"profit":true},{"date":"2022-12-31","value":76.42,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | 3.44B | (8.99B) | 6.99B | 6.33B | 8.03B | [{"date":"2019-12-31","value":42.85,"profit":true},{"date":"2020-12-31","value":-112.09,"profit":false},{"date":"2021-12-31","value":87.15,"profit":true},{"date":"2022-12-31","value":78.84,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
EPS (Diluted) | 4.67 | 6.44 | 7.50 | 7.80 | 7.39 | [{"date":"2019-12-31","value":59.87,"profit":true},{"date":"2020-12-31","value":82.56,"profit":true},{"date":"2021-12-31","value":96.15,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":94.74,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
BMY | |
---|---|
Cash Ratio | 0.36 |
Current Ratio | 1.24 |
Quick Ratio | 1.09 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
BMY | |
---|---|
ROA (LTM) | 6.07% |
ROE (LTM) | -31.33% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
BMY | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.82 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.18 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
BMY | |
---|---|
Trailing PE | NM |
Forward PE | 7.89 |
P/S (TTM) | 2.46 |
P/B | 6.61 |
Price/FCF | 22 |
EV/R | 3.30 |
EV/Ebitda | 30.89 |
PEG | 1.92 |
Bristol-Myers Squibb Company (BMY) share price today is $56.3
Yes, Indians can buy shares of Bristol-Myers Squibb Company (BMY) on Vested. To buy Bristol-Myers Squibb Company from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BMY stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Bristol-Myers Squibb Company (BMY) via the Vested app. You can start investing in Bristol-Myers Squibb Company (BMY) with a minimum investment of $1.
You can invest in shares of Bristol-Myers Squibb Company (BMY) via Vested in three simple steps:
The 52-week high price of Bristol-Myers Squibb Company (BMY) is $61.08. The 52-week low price of Bristol-Myers Squibb Company (BMY) is $38.6.
The price-to-earnings (P/E) ratio of Bristol-Myers Squibb Company (BMY) is
The price-to-book (P/B) ratio of Bristol-Myers Squibb Company (BMY) is 6.61
The dividend yield of Bristol-Myers Squibb Company (BMY) is 4.44%
The market capitalization of Bristol-Myers Squibb Company (BMY) is $116.92B
The stock symbol (or ticker) of Bristol-Myers Squibb Company is BMY